Skip to main content
Caplight Logo









Delsona Therapeutics

Delsona Therapeutics

Private
New York City, New YorkHealthcare & Life Scienceshttps://delsona.com/

Last Round

Accelerator

Dec 14, 2023

Company Overview

Delsona Therapeutics is a clinical-stage therapeutics company developing a drug delivery platform, called UltraNav, which uses focused ultrasound to non-invasively open the blood-brain barrier for treating life-threatening diseases of the brain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

focused ultrasoundblood-brain barrier openingdrug delivery platformFUSbrain drug deliverymedical deviceMedTechblood-brain barrierBBBclinical-stage companyneuronavigationpediatric brain cancerAlzheimer's diseasemicrobubble-enhanced ultrasoundneurodegenerative diseasebiotechnologycentral nervous system diseasesCNS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delsona Therapeutics Comparables

Compare Delsona Therapeutics with similar companies based on industry and business-model similarity.

Delsona Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cordance Medical
84%
NaviFUS Corp.
82%
Ceretas
82%

Delsona Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 14, 2023

Delsona Therapeutics Investors

Notable investors and investment history

Delsona Therapeutics investors
InvestorRounds
Westchester County Biosciences AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 14, 2023

    Received funding from Westchester County Biosciences Accelerator.

Delsona Therapeutics Filings

Explore SEC and related filing metadata, where available.

Delsona Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Delsona Therapeutics's valuation, stock price, and market status.

Is Delsona Therapeutics a public or private company?

Delsona Therapeutics is a private company.

What is the current stock price of Delsona Therapeutics?

Delsona Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Delsona Therapeutics worth (valuation)?

Valuation information for Delsona Therapeutics is not publicly available.

Can I buy Delsona Therapeutics stock?

Delsona Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Delsona Therapeutics's last funding round?

Delsona Therapeutics's most recent funding round was Accelerator on December 14, 2023.

Who are the main investors in Delsona Therapeutics?

Key investors in Delsona Therapeutics include Westchester County Biosciences Accelerator.

Will Delsona Therapeutics IPO soon?

No public IPO plans have been announced for Delsona Therapeutics.

How can I track Delsona Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delsona Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A
Last FundingDec 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?